Holen Sie sich die Stockscreener-App
83.34
4.67%
-4.08
Vorhandelsmarkt:
82.70
-0.64
-0.77%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$87.42
Offen:
$86.45
24-Stunden-Volumen:
5.40M
Relative Volume:
1.68
Marktkapitalisierung:
$42.75B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
150.95
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
-2.39%
1M Leistung:
-4.25%
6M Leistung:
-4.83%
1J Leistung:
+18.97%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$83.14
$88.10
52-Wochen-Spanne:
$68.15
$101.60
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
83.34 | 42.75B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
226.72 | 163.37B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
46.13 | 13.98B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
19.02 | 13.11B | 2.87B | 250.10M | 1.13B | 0.3188 |
AHR
American Healthcare Reit Inc
|
51.06 | 11.13B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-15 | Fortgesetzt | Jefferies | Buy |
| 2026-07-07 | Eingeleitet | Barclays | Equal Weight |
| 2026-06-17 | Fortgesetzt | Raymond James | Outperform |
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Ventas, Inc. Stock 12‑Month Price Target Cut to $100, Implies 20% Upside - TradingView
Ventas (NYSE:VTR) Announces Earnings Results - MarketBeat
Ventas, Inc. reports results for the quarter ended September 30Earnings Summary - TradingView
Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research
Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Ventas Q3 earnings, revenue beat on senior housing organic growth - TradingView
VENTAS ($VTR) Releases Q3 2026 Earnings - Quiver Quantitative
Ventas Q3 Normalized FFO, Revenue Rise - www.marketscreener.com
Ventas, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 - www.marketscreener.com
(VTR) Ventas Now Expects 2026 Normalized FFO Range $3.87-$3.90 - marketscreener.com
Earnings Flash (VTR) Ventas, Inc. Reports Q3 Revenue $1.83B, vs. FactSet Est of $1.77B - marketscreener.com
Ventas (VTR) Q3 FFO and Revenues Top Estimates - Zacks Investment Research
Ventas (VTR) Q3 FFO and Revenues Top Estimates - Yahoo Finance
Ventas Reports 2026 Third Quarter Results - Business Wire
Ventas Falls as Investors Appear to Brace for Earnings and Digest a Recent Target Cut - Quiver Quantitative
Ventas faces earnings test as senior housing boom meets rate pressure - Investing.com Canada
Equinix to Post Q3 Earnings: What's in Store for the Stock? - Zacks Investment Research
BXP to Post Q3 Earnings: Is the Stock a Portfolio Must-Have? - Zacks Investment Research
What's in the Offing for Ventas Stock This Earnings Season? - Zacks Investment Research
What's in the Offing for Ventas Stock This Earnings Season? - TradingView
Welltower Gears Up to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
What to Expect From Ventas’ Q3 2026 Earnings Report - Barchart.com
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
19,741 Ventas, Inc. $VTR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Wells Fargo cuts target for Ventas stock to USD 96 - ad-hoc-news.de
VTR Q3'26 Earnings: revenue estimate is 1.77B USD - TradingView
Ventas (VTR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Ventas Price Target Cut to $96.00/Share From $104.00 by Wells Fargo - Moomoo
Ventas, Inc. acquired HarborChase of Palm Beach Gardens from Silverstone Healthcare Company, LLC for $28.6 million. - www.marketscreener.com
VTR Maintained by Wells Fargo -- Price Target Lowered to $96.00 - GuruFocus
35,949 Shares of Ventas, Inc. $VTR Bought by SteelPeak Wealth LLC - MarketBeat
Ventas (NYSE:VTR) Stock Forecast & Analyst Predictions - Simply Wall Street
Ventas vs. Welltower: Which Senior Housing REIT Pays Retirees Better? - Yahoo Finance
Ventas, Inc. $VTR Holdings Reduced by Curated Wealth Partners LLC - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Form 4 Ventas Inc: Joe Vasquez Rodriguez Jr (Director) For: 15 October - Investing.com Nigeria
A 17.889-unit stock grant replaces director fees for Ventas (VTR) director Maurice S. Smith. - Stock Titan
Ventas (VTR) director Roy receives 55.161 and 80.645 stock units from dividend equivalents. - Stock Titan
Dividend credits give a director 80.645 stock units at Ventas (VTR). - Stock Titan
Dividend credits bring 55 stock units to a Ventas (VTR) director - Stock Titan
18 stock units for fees and 199 tied to dividends go to Ventas (VTR) director Martino. - Stock Titan
Dividend equivalents give Ventas (VTR) director Lustig 238.848 and 80.645 stock units. - Stock Titan
15,647 Ventas, Inc. $VTR Shares Bought by State of Alaska Department of Revenue - MarketBeat
Ventas (VTR) Targets Up to 17% NOI Growth and Expands Acquisition Budget to $3 Billion - Yahoo Finance
Barclays Adjusts Price Target on Ventas to $91 From $102 - Yahoo Finance
Ventas Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Ventas (VTR) Pays Out Over 370% of Its Earnings as Dividends, So What Actually Funds It? - Yahoo Finance
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ventas Inc-Aktie (VTR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Walter C. Rakowich | Director |
May 14 '26 |
Proposed Sale |
90.16 |
1,152 |
103,864 |
0 |
| RAKOWICH WALTER C | Director |
May 14 '26 |
Sale |
90.20 |
1,152 |
103,915 |
28,349 |
| GREGORY LIEBBE | Officer |
Mar 02 '26 |
Proposed Sale |
86.31 |
17,248 |
1,488,620 |
0 |
| Roberts Carey S. | EVP and GC |
Feb 11 '26 |
Sale |
85.00 |
35,532 |
3,020,117 |
72,755 |
| CAREY SHEA ROBERTS | Officer |
Feb 11 '26 |
Proposed Sale |
85.00 |
35,532 |
3,020,117 |
0 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 06 '26 |
Option Exercise |
73.71 |
10,322 |
760,835 |
1,124,356 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 06 '26 |
Sale |
82.23 |
10,322 |
848,751 |
1,114,034 |
| CAFARO DEBRA A | Officer |
Feb 06 '26 |
Proposed Sale |
82.23 |
10,322 |
848,751 |
0 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 02 '26 |
Option Exercise |
73.71 |
10,322 |
760,835 |
1,124,356 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 02 '26 |
Sale |
77.66 |
10,322 |
801,605 |
1,114,034 |
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):